IQ-AI Ltd

  • News & Announcements
  • Shareholder Information
  • Investor Relations
  • Significant Shareholders
  • Publications
  • Home
  • Corporate News & Announcements
  • IQ-AI RNS News & Announcements
  • Issue of Convertible Loan Notes
 

News

Monday, 11 March 2019 / Published in IQ-AI RNS News & Announcements

Issue of Convertible Loan Notes

RNS Number : 3697S
IQ-AI Limited
11 March 2019
 

IQ-AI LIMITED

(“IQ-AI” or the “Company“)

 

Issue of Convertible Loan Notes

 

 

IQ-AI is pleased to announce that the Company has issued £268,500 in nominal amount of 6% unsecured convertible loan notes 2024, convertible into 13,425,000 ordinary shares of 0.1p each in the Company (“Ordinary Shares”) at a price of 2 pence per share (“CLNs”). The funds raised as a result of the issue of the CLNs will be used to provide additional working capital for the Company. The funds raised enables the Company to fully execute its current business plan and shareholders should take comfort that the Company is now able to fully execute its current strategic objectives, following this, initially, non-dilutive fundraise. 

Trevor Brown, Chairman of the Company, has subscribed for £250,000 of the CLNs and Michael Schmainda, Chief Executive Officer of the Company’s 100% owned subsidiary, Imaging Biometrics LLC, has subscribed for £18,500 of the CLNs. 

Trevor Brown is directly and indirectly (through Free Association Books, a company in which he is interested) interested in 36,083,025 Ordinary Shares, equivalent to 29.98% of the issued ordinary share capital. Following the issue of the CLNs, Trevor Brown holds £546,926 of loan notes, directly and through Free Association Books. 

The Directors of the Company accept responsibility for the contents of this announcement. 

This announcement contains inside information as stipulated under the Market Abuse Regulations (EU) no. 596/2014 (“MAR”).

 

 **ENDS**

 

For further information please contact:

 

Flying Brands Limited

Qu Li/Trevor Brown/Vinod Kaushal

Tel:  020 7469 0930

 

 

 

Peterhouse Capital Limited (Financial Advisor and Broker)

Lucy Williams and Fungai Ndoro

Tel: 020 7220 9797

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Article source

Recent Posts

  • Notice of AGM

    RNS Number : 4440K IQ-AI Limited 05 May 2022   ...
  • IB Broadens Quantitative Mapping

    RNS Number : 1476K IQ-AI Limited 03 May 2022   ...
  • IB Broadens Quantitative Mapping

    – Article source...
  • Final Results

    RNS Number : 7683J IQ-AI Limited 28 April 2022 ...
  • IQAI’s Sponsored Phase I Clinical Trial is Open

    RNS Number : 2319E IQ-AI Limited 09 March 2022 ...
Portions copyright © 2010-2022 IQ-AI Ltd. All Rights Reserved.
TOP
Our website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.AcceptReject
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT